Your browser doesn't support javascript.
loading
Population health outcomes in Nigeria compared with other west African countries, 1998-2019: a systematic analysis for the Global Burden of Disease Study.
Angell, Blake; Sanuade, Olutobi; Adetifa, Ifedayo M O; Okeke, Iruka N; Adamu, Aishatu Lawal; Aliyu, Muktar H; Ameh, Emmanuel A; Kyari, Fatima; Gadanya, Muktar A; Mabayoje, Diana A; Yinka-Ogunleye, Adesola; Oni, Tolu; Jalo, Rabiu Ibrahim; Tsiga-Ahmed, Fatimah I; Dalglish, Sarah L; Abimbola, Seye; Colbourn, Tim; Onwujekwe, Obinna; Owoaje, Eme Theodora; Aliyu, Gambo; Aliyu, Sani H; Archibong, Belinda; Ezeh, Alex; Ihekweazu, Chikwe; Iliyasu, Zubairu; Obaro, Stephen; Obadare, Ebenezer Babatunde; Okonofua, Friday; Pate, Muhammed; Salako, Babatunde L; Zanna, Fatima H; Glenn, Scott; Walker, Ally; Ezalarab, Maha; Naghavi, Mohsen; Abubakar, Ibrahim.
Affiliation
  • Angell B; UCL Institute for Global Health, University College London, London, UK; The George Institute for Global Health, University of New South Wales, Sydney, Sydney, NSW, Australia.
  • Sanuade O; UCL Institute for Global Health, University College London, London, UK; Center for Global Cardiovascular Health, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Adetifa IMO; Department of Infectious Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Department of Epidemiology and Demography, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Paediatrics and Child Health, College of Medicine,
  • Okeke IN; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.
  • Adamu AL; Department of Infectious Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Department of Epidemiology and Demography, Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Community Medicine, Bayero University, Aminu Kano
  • Aliyu MH; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Ameh EA; Division of Paediatric Surgery, National Hospital, Abuja, Nigeria.
  • Kyari F; College of Health Sciences, University of Abuja, Abuja, Nigeria.
  • Gadanya MA; Department of Community Medicine, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Mabayoje DA; University College London Hospitals NHS Foundation Trust, London, UK.
  • Yinka-Ogunleye A; UCL Institute for Global Health, University College London, London, UK; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Oni T; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK; Research Initiative for Cities Health and Equity, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
  • Jalo RI; Department of Community Medicine, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Tsiga-Ahmed FI; Department of Community Medicine, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Dalglish SL; UCL Institute for Global Health, University College London, London, UK.
  • Abimbola S; School of Public Health, University of Sydney, Sydney, NSW, Australia.
  • Colbourn T; UCL Institute for Global Health, University College London, London, UK.
  • Onwujekwe O; Health Policy Research Group, University of Nigeria Enugu Campus, Enugu, Nigeria.
  • Owoaje ET; Department of Community Medicine, University of Ibadan College of Medicine, Ibadan, Nigeria.
  • Aliyu G; National Agency for the Control of AIDS, Abuja, Nigeria.
  • Aliyu SH; Infectious Disease and Microbiology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Archibong B; Barnard College, New York, NY, USA.
  • Ezeh A; Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA.
  • Ihekweazu C; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Iliyasu Z; Department of Community Medicine, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Obaro S; Department of Pediatric Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
  • Obadare EB; Sociology Department, University of Kansas, Lawrence, KA, USA.
  • Okonofua F; Centre of Excellence in Reproductive Health Innovation, University of Benin, Benin City, Edo State, Nigeria; University of Medical Sciences, Ondo City, Nigeria.
  • Pate M; Health, Nutrition, and Population Global Practice and Global Financing Facility for Women, Children and Adolescents, World Bank, Washington, DC, USA; Harvard T H Chan School of Public Health, Cambridge, MA, USA.
  • Salako BL; Nigeria Institute for Medical Research, Lagos, Nigeria.
  • Zanna FH; National Agency for the Control of AIDS, Abuja, Nigeria.
  • Glenn S; Institute for Health Metrics and Evaluation, University of Medicine Washington, Seattle, WA, USA.
  • Walker A; Institute for Health Metrics and Evaluation, University of Medicine Washington, Seattle, WA, USA.
  • Ezalarab M; Institute for Health Metrics and Evaluation, University of Medicine Washington, Seattle, WA, USA.
  • Naghavi M; Institute for Health Metrics and Evaluation, University of Medicine Washington, Seattle, WA, USA.
  • Abubakar I; UCL Institute for Global Health, University College London, London, UK. Electronic address: i.abubakar@ucl.ac.uk.
Lancet ; 399(10330): 1117-1129, 2022 03 19.
Article in En | MEDLINE | ID: mdl-35303469
BACKGROUND: Population-level health and mortality data are crucial for evidence-informed policy but scarce in Nigeria. To fill this gap, we undertook a comprehensive assessment of the burden of disease in Nigeria and compared outcomes to other west African countries. METHODS: In this systematic analysis, using data and results of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019, we analysed patterns of mortality, years of life lost (YLLs), years lived with disability (YLDs), life expectancy, healthy life expectancy (HALE), and health system coverage for Nigeria and 15 other west African countries by gender in 1998 and 2019. Estimates of all-age and age-standardised disability-adjusted life-years for 369 diseases and injuries and 87 risk factors are presented for Nigeria. Health expenditure per person and gross domestic product were extracted from the World Bank repository. FINDINGS: Between 1998 and 2019, life expectancy and HALE increased in Nigeria by 18% to 64·3 years (95% uncertainty interval [UI] 62·2-66·6), mortality reduced for all age groups for both male and female individuals, and health expenditure per person increased from the 11th to third highest in west Africa by 2018 (US$18·6 in 2001 to $83·75 in 2018). Nonetheless, relative outcomes remained poor; Nigeria ranked sixth in west Africa for age-standardised mortality, seventh for HALE, tenth for YLLs, 12th for health system coverage, and 14th for YLDs in 2019. Malaria (5176·3 YLLs per 100 000 people, 95% UI 2464·0-9591·1) and neonatal disorders (4818·8 YLLs per 100 000, 3865·9-6064·2) were the leading causes of YLLs in Nigeria in 2019. Nigeria had the fourth-highest under-five mortality rate for male individuals (2491·8 deaths per 100 000, 95% UI 1986·1-3140·1) and female individuals (2117·7 deaths per 100 000, 1756·7-2569·1), but among the lowest mortality for men older than 55 years. There was evidence of a growing non-communicable disease burden facing older Nigerians. INTERPRETATION: Health outcomes remain poor in Nigeria despite higher expenditure since 2001. Better outcomes in countries with equivalent or lower health expenditure suggest health system strengthening and targeted intervention to address unsafe water sources, poor sanitation, malnutrition, and exposure to air pollution could substantially improve population health. FUNDING: The Bill & Melinda Gates Foundation.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Global Burden of Disease / Population Health Type of study: Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Newborn Country/Region as subject: Africa Language: En Journal: Lancet Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Global Burden of Disease / Population Health Type of study: Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Newborn Country/Region as subject: Africa Language: En Journal: Lancet Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Reino Unido